Advances in single-cell sequencing technology and its application in eye diseases
Journal Title: Eye Science - Year 2024, Vol 1, Issue 2
Abstract
Vision serves as the cornerstone of rountine human life activities, wherein approximately 80% of information is perceived visually. Eye diseases, however, frequently culminate in vision impairment or blindness, severely affecting the quality of life. Due to the obscurity of the underlying molecular mechanisms, therapeutic outcomes for various blinding eye diseases remain suboptimal. Over the past decade, the development of single-cell genomics technology has made it possible to obtain multi-dimensional insights into genomes, epigenomes, transcriptomes, and proteomes of tissues and organs at the single-cell level, providing a potent tool for elucidating the molecular mechanisms of eye diseases and advancing precision diagnosis. Meanwhile, single-cell genomics technology has also been harnessed in drug discovery and screening, promising to transform traditional drug development paradigm that is often characterized by high cost[1], time-consuming[2], and substantial failure rate. This review aims to describe the cutting-edge advances in single-cell omics technology and its applications in precision diagnosis of eye diseases as well as drug discovery and screening.
Authors and Affiliations
Zheyao Chen, Youjin Hu
Keywords
Related Articles
- EP ID EP768750
- DOI 10.12419/es24031802
- Views 6
- Downloads 0
From barn lanterns to the 5G Intelligent Ophthalmic Cruiser: The perspective of artificial intelligence and digital technologies on the modality and efficiency of blindness prevention in China
Blindness prevention has been an important national policy in China. Previous strategies, such as deploying experienced cataract surgeons to rural areas and assisting in building local ophthalmology centers, had successf...
Harnessing AI-human synergy for deep learning research analysis in ophthalmology with large language models assisting humans
[Background] Research innovations inocular disease screening, diagnosis, and management have been boosted by deep learning (DL) in the last decade. To assess historical research trends and current advances, we conducted...
Identification of novel drug targets for diabetic retinopathy: proteome-wide mendelian randomization and colocalization analyses
[Background] Diabetic retinopathy (DR) urgently needs novel and effective therapeutic targets. Integrated analyses of plasma proteomic and genetic markers can clarify the causal relevance of proteins and discover novel t...
Role of omics approaches in the study of pediatric cataract
Pediatric cataract, a leading cause of blindness in children globally, imposing a significant financial burden on both families and society. The extensive phenotypic heterogeneity of this condition means that the underly...
The journey to discovery for treatments of retinal hemangioblastomas associated with von Hippel-Lindau disease
Retinal hemangioblastomas (RHs) are among the most common manifestations of von Hippel-Lindau (VHL) disease, an autosomal dominant genetic disorder that predisposes individuals to various tumors, particularly in the reti...